We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+22.62%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.77B
AUM Growth
+$282M
Cap. Flow
+$179M
Cap. Flow %
10.07%
Top 10 Hldgs %
30.07%
Holding
2,442
New
714
Increased
405
Reduced
476
Closed
723

Sector Composition

Rank Sector Weight
1 Technology 7.8%
2 Healthcare 6.74%
3 Communication Services 5.4%
4 Consumer Discretionary 5.34%
5 Real Estate 3.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WTW icon
1326
CALL
Willis Towers Watson
WTW
$32B
$18K ﹤0.01%
+100
New +$16.6K
EIGR
1327
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$18K ﹤0.01%
44
-482
-92% -$193K
CLVS
1328
DELISTED
Clovis Oncology, Inc.
CLVS
$18K ﹤0.01%
710
+695
+4,633% +$17.4K
QADA
1329
DELISTED
QAD Inc.
QADA
$18K ﹤0.01%
419
BBY icon
1330
Best Buy
BBY
$17.3B
$17K ﹤0.01%
245
-3,091
-93% -$193K
ENS icon
1331
EnerSys
ENS
$6.99B
$17K ﹤0.01%
+258
New +$19.5K
MOG.A icon
1332
Moog Inc Class A
MOG.A
$12.8B
$17K ﹤0.01%
+197
New +$17.2K
RIGL icon
1333
Rigel Pharmaceuticals
RIGL
$750M
$17K ﹤0.01%
643
-101
-14% -$2.31K
RLGT icon
1334
Radiant Logistics
RLGT
$395M
$17K ﹤0.01%
2,750
+1,160
+73% +$6.38K
WK icon
1335
Workiva
WK
$3.54B
$17K ﹤0.01%
+340
New +$14.9K
PAMT
1336
PAMT Corp
PAMT
$297M
$17K ﹤0.01%
1,420
-3,288
-70% -$40.6K
IVC
1337
DELISTED
Invacare Corporation
IVC
$17K ﹤0.01%
+1,982
New +$14.3K
BF.B icon
1338
Brown-Forman Class B
BF.B
$13.1B
$16K ﹤0.01%
310
-31
-9% -$1.5K
LNTH icon
1339
Lantheus
LNTH
$6.59B
$16K ﹤0.01%
669
+143
+27% +$2.86K
MRCY icon
1340
Mercury Systems
MRCY
$6.52B
$16K ﹤0.01%
+256
New +$14.8K
PBYI icon
1341
Puma Biotechnology
PBYI
$454M
$16K ﹤0.01%
400
ENDP
1342
CALL
DELISTED
Endo International plc
ENDP
$16K ﹤0.01%
+2,000
New +$18.8K
IESC icon
1343
IES Holdings
IESC
$15.2B
$15K ﹤0.01%
849
+373
+78% +$6.6K
UNFI icon
1344
CALL
United Natural Foods
UNFI
$2.85B
$15K ﹤0.01%
1,100
-100
-8% -$1.35K
NTUS
1345
DELISTED
Natus Medical Inc
NTUS
$15K ﹤0.01%
+600
New +$17.9K
PRSP
1346
DELISTED
Perspecta Inc. Common Stock
PRSP
$15K ﹤0.01%
+721
New +$14.5K
CETV
1347
DELISTED
Central European Media Enterprises Ltd
CETV
$15K ﹤0.01%
3,663
+1,785
+95% +$6.02K
LABL
1348
PUT
DELISTED
Multi-Color Corp
LABL
$15K ﹤0.01%
+300
New +$14K
ANGO icon
1349
AngioDynamics
ANGO
$649M
$14K ﹤0.01%
+606
New +$13.2K
ARW icon
1350
Arrow Electronics
ARW
$10.4B
$14K ﹤0.01%
182

Similar funds

Prelude Capital Management's Q1 2019 Portfolio in Review

As of Q1 2019, Prelude Capital Management held 2,442 positions worth $1.77B, up 19% from $1.49B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Prelude Capital Management deployed $179M of net new capital in Q1 2019, opening 714 new positions and adding to 405 existing holdings. Its largest new stake was Ultimate Software Group Inc: 57,473 shares worth $19M.

By sector, the portfolio is most concentrated in Technology at 7.8% of assets, down from 12% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Integrated Device Technology I, an estimated $12.7M trimmed.

  • Prelude Capital Management's largest Q1 2019 buy was Ultimate Software Group Inc: 57,473 shares worth $19M.
  • Prelude Capital Management added most to Celgene Corp in Q1 2019, an estimated $43.9M increase.
  • Prelude Capital Management's biggest Q1 2019 reduction was Integrated Device Technology I, cutting an estimated $12.7M.
  • Prelude Capital Management fully exited Twenty-First Century Fox, Inc. Class B in Q1 2019, selling an estimated $47.3M.
  • Prelude Capital Management's ten largest holdings make up 30% of its $1.77B portfolio in Q1 2019.
  • Prelude Capital Management opened 714 new positions and closed 723 in Q1 2019.
  • Prelude Capital Management's portfolio value rose 19% quarter-over-quarter to $1.77B.

Based on Prelude Capital Management's 13F filing for Q1 2019, filed 15 May 2019.